TrialBMC cancer2022

Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.

Edward Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.